← Back to Investors

Sofinnova Partners

Sofinnova Partners is one of the leading European venture capital firms dedicated exclusively to life sciences. With over 50 years of experience, the firm invests across therapeutics, medical devices, diagnostics, and digital health, and has backed numerous successful companies that have transformed patient care.

Location
Paris, France
Founded
1972
AUM
€3B+
Investment Range
€5M - €50M
Portfolio Companies
23
Focus
biotech-focused
Fund Stages
seed, series-a, series-b, series-c, growth

Portfolio Companies

NameLocationFoundedCategories
Enthera PharmaceuticalsMilan, Italy2016
biotechautoimmune+3
ENYO PharmaLyon, France2014
biotechtherapeutics+3
DeliniaWatertown, Massachusetts, USA2020
biotechautoimmune+3
DISCO Pharmaceutical--
biotechpharmaceuticals+1
CinCor PharmaWaltham, Massachusetts, USA2018
biotechpharmaceuticals+3
Corvidia TherapeuticsWaltham, Massachusetts, USA2015
biotechcardiovascular+3
CorWaveClichy, France2012
medical-devicescardiovascular+3
Crescendo BiologicsCambridge, United Kingdom2009
biotechimmuno-oncology+3
Cure51Paris, France2021
digital-medicineai+3
DBV TechnologiesBagneux, France2002
biotechallergy+3
deepcMunich, Germany2017
digital-medicineai+3
Elevara Medicine--
biotechautoimmune+3
Endoron MedicalIsrael-
medical-devicesvascular+2
EnginZymeStockholm, Sweden2014
industrial-biotechenzymes+3
DNA ScriptParis, France & San Francisco, California, USA2014
biotechdna-synthesis+3
Hemab TherapeuticsCopenhagen, Denmark2020
biotechhematology+2
MISSION TherapeuticsCambridge, United Kingdom2011
biotechmitochondria+3
NanoPhoriaParis, France2021
biotechdrug-delivery+3
One BiosciencesBengaluru, India2020
biotechsingle-cell+2
Arzeda CorporationSeattle, Washington, USA2008
biotechprotein-design+3
KiroParis, France2020
digital-medicineai+3
BioCorteXMunich, Germany2018
digital-medicineai+3
BetteromicsParis, France2019
digital-medicinedata-platform+3